AIR INDUSTRIES GROUP (AIRI): Nasdaq/NYSE listing notice — Air Industries receives NYSE American non-compliance notice for late 10-Q filing

AIR INDUSTRIES GROUP

Received notice on May 23, 2023 for failure to file Q1 2023 Form 10-Q by May 22, 2023 due date.
Has six-month cure period until November 22, 2023 to file the delinquent report.
Stock to continue trading with '.LF' indicator during cure period, subject to other listing requirements.
Company expects to file Form 10-Q as soon as practicable; Annual 10-K filed on May 16, 2023.
If not cured, Exchange may grant an additional six-month cure period or commence delisting procedures.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

AIR INDUSTRIES GROUP received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

Exchange: nyse american
Notice: noncompliance notice
Deficiency: late filing
Rules: 1007

Exact text from the filing

May 23, 2023, Air Industries Group (the “Company”) received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American (the “Exchange”) under the timely filing criteria included in Section 1007 of the NYSE American Company Guide (the “Company Guide”) because the Company failed to file by the extended due date of May 22, 2023, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”). In accordance with Section 1007 of the Company Guide, the Company will have six months from the date of the

View on SEC.gov

Browse all listing & compliance notices →

AIR INDUSTRIES GROUP filing history →

Source: SEC EDGAR

accession 0001213900-23-044030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.